Biotech news
Americas
Biotech company Momenta has obtained the rights to use AbbVie’s Humira IP, enabling the global commercialisation of Momenta’s proposed Humira biosimilar, M923. 8 November 2018
Americas
Womble Bond Dickinson has strengthened its Boston-based life sciences team with the addition of patent attorney Briana Erickson. 7 November 2018
Americas
Pfizer has entered into an oncology collaboration with Nektar Therapeutics, a US development stage biopharma company. 7 November 2018
Americas
Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report. 6 November 2018
Americas
California-based Gilead Sciences has signed a collaboration agreement with Tango Therapeutics to discover and develop a pipeline of immuno-oncology treatments for cancer patients. 2 November 2018
Americas
Alex Tse, US attorney for the Northern District of California, has charged three former Genentech employees with trade secrets theft. 1 November 2018
Pharma
Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire. 31 October 2018
Americas
With several major drugs set to face generic or biosimilar competition as patent protection expires, LSIPR analyses how well prepared their manufacturers are and how badly their sales may be affected. 26 October 2018
Americas
Siew Yen Chong has joined Nelson Mullins Riley & Scarborough’s New York office as of counsel. 26 October 2018
Americas
Duane Morris has appointed Patrick Gallagher as chair of the firm’s pharmaceuticals and biopharmaceuticals litigation and regulatory practice group. 25 October 2018